How treatment paradigms regarding HPV-positive squamous cell carcinoma will evolve, particularly in the era of precision medicine, is a provocative question and is the subject of this review.
Allen M. Chen, MD, MBA
Advertisement
Articles by Allen M. Chen, MD, MBA
Advertisement
Latest Updated Articles
De-Escalation Treatment for Human Papillomavirus–Related Oropharyngeal Cancer: Questions for Practical ConsiderationPublished: July 26th 2023 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
3
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
4
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
5
